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Abstract: Melanoma is the leading cause of skin-cancer related deaths in North America. Metastatic 
melanoma is difficult to treat and chemotherapies have limited success. Furthermore, chemotherapies lead to 
toxic side effects due to nonselective targeting of normal cells. Curcumin is a natural product of Curcuma 
longa (turmeric) and has been shown to possess anti-cancer activity. However, due to its poor bioavailability 
and stability, natural curcumin is not an effective cancer treatment. We tested synthetic analogs of curcumin 
that are more stable. One of these derivatives, Compound A, has shown significant anti-cancer efficacy in 
colon, leukemia, and triple-negative inflammatory breast cancer cells. However, the effects of Compound A 
against melanoma cells have not been studied before. In this study, for the first time, we demonstrated the 
efficacy of Compound A for the selective induction of apoptosis in melanoma cells and its interaction with 
tamoxifen, taxol, and cisplatin. We found that Compound A induced apoptosis selectively in human melanoma 
cells by increasing oxidative stress. The anti-cancer activity of Compound A was enhanced when combined 
with tamoxifen and the combination treatment did not result in significant toxicity to noncancerous cells. 
Additionally, Compound A did not interact negatively with the anti-cancer activity of taxol and cisplatin. 
These results indicate that Compound A could be developed as a selective and effective melanoma treatment 
either alone or in combination with other non-toxic agents like tamoxifen.  
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